https://www.selleckchem.com/pr....oducts/pd0166285.htm
0001; 6.75 ± 1.72 vs. 19.09 ± 3.1, p = 0.0012, respectively). Our results provide further evidence that DPP4i-associated BP differs significantly from classical BP, and presents with less distributed skin symptoms, mild erythema, normal or slightly elevated peripheral eosinophil count, and lower titers of BP180 autoantibodies. To our knowledge, this is the first case series of DPP4i-related BP with a non-inflammatory phenotype in European patients.Motto [...].We evaluated the bioavailability, liver distribution, and efficacy of silyma
Curtir
Comentario
Compartilhar
